Integrated Micro-Electronics, Inc. (PSE:IMI)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	119.9	91.94	103.01	115.82	159.79	244.36
Short-Term Investments	3.53	-	-	8.5	-	-
Cash & Short-Term Investments	123.43	91.94	103.01	124.32	159.79	244.36
Cash Growth	37.05%	-10.74%	-17.15%	-22.19%	-34.61%	60.07%
Accounts Receivable	268.32	264.06	330.33	357.65	330.09	329.28
Other Receivables	-	9.29	14.2	5.11	3.1	2.88
Receivables	268.32	273.35	344.52	362.75	333.19	332.15
Inventory	185.64	205.95	273.5	273.41	244.92	147.75
Prepaid Expenses	-	4.32	5.84	8.34	9.45	5.81
Other Current Assets	24.69	14.04	12.46	8.02	4.98	4.1
Total Current Assets	602.08	589.59	739.33	776.85	752.33	734.17
Property, Plant & Equipment	137.38	143.24	158.2	165.37	190.43	210.61
Long-Term Investments	2.62	2.54	2.36	1.83	1.36	1.12
Goodwill	40.68	40.46	70.18	136.25	145.43	147.25
Other Intangible Assets	3.04	2.91	3.47	4.79	6.7	10.59
Long-Term Deferred Tax Assets	2.76	3.13	3.65	2.15	2.93	3.49
Long-Term Deferred Charges	-	7.75	13.57	12.62	19.95	24.76
Other Long-Term Assets	9.26	3.3	3.87	4.03	4.04	1.68
Total Assets	797.83	792.92	994.63	1,104	1,123	1,134
Accounts Payable	226.87	157.67	197.24	212.11	205.36	176.56
Accrued Expenses	-	53.71	56.88	64.52	65.4	60.06
Short-Term Debt	167.2	152.59	210.03	192.66	165.77	206.49
Current Portion of Long-Term Debt	5.53	30.76	6.48	3.05	1.81	2.11
Current Portion of Leases	4.02	5.44	8.27	7.07	8.42	7.79
Current Income Taxes Payable	2.17	1.76	2.01	1.78	2.41	3.35
Current Unearned Revenue	3.34	3.44	2.75	7.41	4.74	1.52
Other Current Liabilities	1.03	18.2	30.86	26.17	18.66	18.89
Total Current Liabilities	410.16	423.58	514.52	514.77	472.56	476.76
Long-Term Debt	98.17	107.1	140.21	147.37	149.68	32.21
Long-Term Leases	22.3	25.44	13.72	12.87	22.8	27.63
Long-Term Unearned Revenue	-	0	0	3.13	2.84	2.49
Long-Term Deferred Tax Liabilities	0.97	0.97	1.01	1.11	1.06	1.6
Other Long-Term Liabilities	5.26	5.14	5.74	2.34	2.21	2.77
Total Liabilities	543.48	569.6	684.04	688.6	661.46	552.81
Common Stock	42.72	42.72	42.72	42.72	42.71	42.67
Additional Paid-In Capital	193.76	193.76	193.78	193.8	193.83	193.87
Retained Earnings	47.07	39.48	89.18	194.8	201.56	215.79
Treasury Stock	-1.01	-1.01	-1.01	-1.01	-1.01	-1.01
Comprehensive Income & Other	-31.29	-56.38	-46.19	-53	-32.49	-3.63
Total Common Equity	251.26	218.57	278.48	377.31	404.6	447.69
Minority Interest	3.09	4.75	32.11	37.97	57.11	133.17
Shareholders' Equity	254.35	223.32	310.59	415.28	461.71	580.86
Total Liabilities & Equity	797.83	792.92	994.63	1,104	1,123	1,134
Total Debt	297.22	321.34	378.71	363.01	348.48	276.22
Net Cash (Debt)	-173.79	-229.4	-275.71	-238.69	-188.69	-31.87
Net Cash Per Share	-0.08	-0.10	-0.12	-0.11	-0.09	-0.01
Filing Date Shares Outstanding	2,217	2,217	2,217	2,217	2,217	2,217
Total Common Shares Outstanding	2,217	2,217	2,217	2,217	2,217	2,208
Working Capital	191.92	166.01	224.81	262.07	279.76	257.42
Book Value Per Share	0.11	0.10	0.13	0.17	0.18	0.20
Tangible Book Value	207.53	175.2	204.83	236.27	252.46	289.86
Tangible Book Value Per Share	0.09	0.08	0.09	0.11	0.11	0.13
Buildings	-	103.36	108.97	9.29	101.48	106.72
Machinery	-	169.44	191.76	323.63	263.47	256.17
Construction In Progress	-	3.34	4.7	6.07	3.38	6.21

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.